Nasopharyngeal cancer therapy can result from DNA Viruses Monitored

In cancer treatment require monitoring to know whether the therapy was successful or not. For nasopharyngeal cancer, the UI researchers said that the monitoring of therapy response can be seen from EBV viral DNA.One of the risk factors of nasopharyngeal cancer is the presence of infection by Epstein-Barr Virus (EBV), EBV is known to use humans as hosts to its place of living that is in the